These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 35486340)

  • 1. Intravenous Immunoglobulins Promote an Expansion of Monocytic Myeloid-Derived Suppressor Cells (MDSC) in CVID Patients.
    Simón-Fuentes M; Sánchez-Ramón S; Fernández-Paredes L; Alonso B; Guevara-Hoyer K; Vega MA; Corbí AL; Domínguez-Soto Á
    J Clin Immunol; 2022 Jul; 42(5):1093-1105. PubMed ID: 35486340
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravenous immunoglobulin replacement therapy in the treatment of patients with common variable immunodeficiency disease: an open-label prospective study.
    Kasztalska K; Ciebiada M; Cebula-Obrzut B; Górski P
    Clin Drug Investig; 2011; 31(5):299-307. PubMed ID: 21473654
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravenous immunoglobulin induces proliferation and immunoglobulin synthesis from B cells of patients with common variable immunodeficiency: a mechanism underlying the beneficial effect of IVIg in primary immunodeficiencies.
    Bayry J; Fournier EM; Maddur MS; Vani J; Wootla B; Sibéril S; Dimitrov JD; Lacroix-Desmazes S; Berdah M; Crabol Y; Oksenhendler E; Lévy Y; Mouthon L; Sautès-Fridman C; Hermine O; Kaveri SV
    J Autoimmun; 2011 Feb; 36(1):9-15. PubMed ID: 20970960
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preparations of intravenous immunoglobulins diminish the number and proinflammatory response of CD14+CD16++ monocytes in common variable immunodeficiency (CVID) patients.
    Siedlar M; Strach M; Bukowska-Strakova K; Lenart M; Szaflarska A; Węglarczyk K; Rutkowska M; Baj-Krzyworzeka M; Pituch-Noworolska A; Kowalczyk D; Grodzicki T; Ziegler-Heitbrock L; Zembala M
    Clin Immunol; 2011 May; 139(2):122-32. PubMed ID: 21300572
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Natural History of Untreated Primary Hypogammaglobulinemia in Adults: Implications for the Diagnosis and Treatment of Common Variable Immunodeficiency Disorders (CVID).
    Ameratunga R; Ahn Y; Steele R; Woon ST
    Front Immunol; 2019; 10():1541. PubMed ID: 31379811
    [No Abstract]   [Full Text] [Related]  

  • 6. Intravenous immunoglobulin (IVIG) efficiency in women with common variable immunodeficiency (CVID) decreases significantly during pregnancy.
    Egawa M; Kanegane H; Imai K; Morio T; Miyasaka N
    J Matern Fetal Neonatal Med; 2019 Sep; 32(18):3092-3096. PubMed ID: 29614902
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravenous immunoglobulin replacement induces an in vivo reduction of inflammatory monocytes and retains the monocyte ability to respond to bacterial stimulation in patients with common variable immunodeficiencies.
    Cavaliere FM; Prezzo A; Conti V; Bilotta C; Pulvirenti F; Iacobini M; Quinti I
    Int Immunopharmacol; 2015 Sep; 28(1):596-603. PubMed ID: 26232049
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Common variable immunodeficiency patients display elevated plasma levels of granulocyte activation markers elastase and myeloperoxidase.
    Litzman J; Chovancová Z; Bejdák P; Litzman M; Hel Z; Vlková M
    Int J Immunopathol Pharmacol; 2019; 33():2058738419843381. PubMed ID: 30968712
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IVIg immune reconstitution treatment alleviates the state of persistent immune activation and suppressed CD4 T cell counts in CVID.
    Paquin-Proulx D; Santos BA; Carvalho KI; Toledo-Barros M; Barreto de Oliveira AK; Kokron CM; Kalil J; Moll M; Kallas EG; Sandberg JK
    PLoS One; 2013; 8(10):e75199. PubMed ID: 24130688
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neutrophil and Granulocytic Myeloid-Derived Suppressor Cell-Mediated T Cell Suppression Significantly Contributes to Immune Dysregulation in Common Variable Immunodeficiency Disorders.
    Vlkova M; Chovancova Z; Nechvatalova J; Connelly AN; Davis MD; Slanina P; Travnickova L; Litzman M; Grymova T; Soucek P; Freiberger T; Litzman J; Hel Z
    J Immunol; 2019 Jan; 202(1):93-104. PubMed ID: 30487174
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of Diagnostic Criteria for Common Variable Immunodeficiency Disorders (CVID) in the New Zealand CVID Cohort Study.
    Ameratunga R; Longhurst H; Steele R; Woon ST
    Clin Rev Allergy Immunol; 2021 Oct; 61(2):236-244. PubMed ID: 34236581
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recurrent multi-organism keratoconjunctivitis manifesting as a first presentation of common variable immune deficiency (CVID).
    Ooi KG; Joshua F; Broadfoot A
    Ocul Immunol Inflamm; 2007; 15(5):403-5. PubMed ID: 17972226
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adiponectin Receptors and Pro-inflammatory Cytokines Are Modulated in Common Variable Immunodeficiency Patients: Correlation With Ig Replacement Therapy.
    Polito R; Nigro E; Pecoraro A; Monaco ML; Perna F; Sanduzzi A; Genovese A; Spadaro G; Daniele A
    Front Immunol; 2019; 10():2812. PubMed ID: 31827477
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Health care and infective aspects in patients affected by common variable immunodeficiency assisted in the Lazio Regional Authority Reference Centre for Primary Immunodeficiencies].
    De Santis W; Esposito A; Conti V; Fantauzzi A; Guerra A; Mezzaroma I; Aiuti F
    Infez Med; 2006 Mar; 14(1):13-23. PubMed ID: 16794375
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Persistent Immune Activation in CVID and the Role of IVIg in Its Suppression.
    Paquin-Proulx D; Sandberg JK
    Front Immunol; 2014; 5():637. PubMed ID: 25566250
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravenous immunoglobulin replacement therapy in common variable immunodeficiency induces B cell depletion through differentiation into apoptosis-prone CD21(low) B cells.
    Mitrevski M; Marrapodi R; Camponeschi A; Lazzeri C; Todi L; Quinti I; Fiorilli M; Visentini M
    Immunol Res; 2014 Dec; 60(2-3):330-8. PubMed ID: 25407649
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An enzyme-linked immunospot assay to evaluate Pneumovax response when on intravenous immunoglobulin.
    Izadi N; Knight V; Strand M; Hill HR; Peterson LK; Hauk PJ
    Ann Allergy Asthma Immunol; 2022 Jan; 128(1):61-67.e4. PubMed ID: 34391898
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of IVIG on the hair regrowth in a common variable immune deficiency patient with alopecia universalis.
    Boonyaleepun S; Boonyaleepun C; Schlactus JL
    Asian Pac J Allergy Immunol; 1999 Mar; 17(1):59-62. PubMed ID: 10403010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of intravenous immunoglobulins on in vitro immunoglobulin formation in patients with antibody immunodeficiency.
    Krátká Z; Bártová J; Krystůfková O; Benetková K; Mrklas L; Fucíková T
    APMIS; 2002 Mar; 110(3):205-13. PubMed ID: 12076273
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of intravenous immunoglobulin treatment in children with common variable immunodeficiency.
    Baris S; Ercan H; Cagan HH; Ozen A; Karakoc-Aydiner E; Ozdemir C; Bahceciler NN
    J Investig Allergol Clin Immunol; 2011; 21(7):514-21. PubMed ID: 22312934
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.